These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36999050)
1. Clinical relevance of RNA editing profiles in lung adenocarcinoma. Shi S; Chen S; Wang M; Guo B; He Y; Chen H Front Genet; 2023; 14():1084869. PubMed ID: 36999050 [No Abstract] [Full Text] [Related]
2. A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma. Liu L; Liu J; Deng X; Tu L; Zhao Z; Xie C; Yang L BMC Cancer; 2022 Jun; 22(1):715. PubMed ID: 35768804 [TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of an adenosine-to-inosine RNA editing-based prognostic model for survival prediction of bladder cancer patients. Tang YC; Yang CS; Liang MX; Zhang Y; Liu Y; Zou SH; Shi SF Medicine (Baltimore); 2023 May; 102(19):e33719. PubMed ID: 37171335 [TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Four Adenosine-to-Inosine RNA Editing Site-Relevant Prognostic Signature for Assessing Survival in Breast Cancer Patients. Wan J; Chen S; Zhang A; Liu Y; Zhang Y; Li Q; Yu Z; Wan Y; Yang L; Wang Q Front Oncol; 2022; 12():861439. PubMed ID: 35494026 [TBL] [Abstract][Full Text] [Related]
5. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes. Li F; Niu Y; Zhao W; Yan C; Qi Y Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857 [TBL] [Abstract][Full Text] [Related]
6. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
7. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
8. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma. Wang H; Wei C; Pan P; Yuan F; Cheng J Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305 [TBL] [Abstract][Full Text] [Related]
9. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes. He J; Li W; Li Y; Liu G Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma. Pan J; Gu X; Luo J; Qian X; Gao Q; Li T; Ye L; Li C Front Cell Dev Biol; 2022; 10():1073688. PubMed ID: 36531956 [TBL] [Abstract][Full Text] [Related]
11. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma. Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575 [TBL] [Abstract][Full Text] [Related]
12. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies. Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes. Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449 [TBL] [Abstract][Full Text] [Related]
15. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma. Lin L; Zhang W Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313 [TBL] [Abstract][Full Text] [Related]
17. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma. Chen M; Wang X; Wang W; Gui X; Li Z Front Immunol; 2022; 13():829057. PubMed ID: 35833114 [TBL] [Abstract][Full Text] [Related]
18. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data. He J; Zhang W; Li F; Yu Y Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Immune Implication and Prognostic Value of Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W Front Oncol; 2021; 11():798425. PubMed ID: 35047409 [TBL] [Abstract][Full Text] [Related]
20. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma. Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X Front Genet; 2022; 13():975905. PubMed ID: 36313456 [No Abstract] [Full Text] [Related] [Next] [New Search]